Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5, signaling a backend or frontend update; no user-facing content changes to the study details are evident from the given changes.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics; updated the page’s revision label from v3.6.3 to v3.6.4 to reflect a metadata/version update.SummaryDifference0.2%

- Check30 days agoChange DetectedOvarian cancer and the related topics MedlinePlus Genetics were removed from the page's topic sections. This changes the page's contextual tagging but does not affect the trial details presented.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision tag on the page was updated from v3.6.2 to v3.6.3. This indicates a newer revision of the page or its associated documents rather than a change to study results or eligibility.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, showing a newer build of the page deployment. This indicates a small update to the page, likely a fix or minor enhancement without changing the study text.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded recruitment status text and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a page revision indicator (Revision: v3.6.0). Standardized the Intervention/Treatment heading by replacing 'Intervention / Treatment' and removed the older 'Revision: v3.5.5' tag.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.